Cargando…

Exploring the state of the science in the field of regenerative medicine : challenges of and opportunities for cellular therapies : proceedings of a workshop /

Regenerative medicine holds the potential to create living, functional cells and tissues that can be used to repair or replace those that have suffered potentially irreparable damage due to disease, age, traumatic injury, or genetic and congenital defects. The field of regenerative medicine is broad...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor principal: Markowitz-Shulman, Ariel (rapporteur.)
Autor Corporativo: State of the Science in the Field of Regenerative Medicine: Challenges of and Opportunities for Cellular Therapies (Workshop)
Otros Autores: Forstag, Erin Hammers (rapporteur.), Addie, Siobhan (rapporteur.), Beachy, Sarah H. (rapporteur.)
Formato: Electrónico Congresos, conferencias eBook
Idioma:Inglés
Publicado: Washington, DC : National Academies Press, [2017]
Colección:Online access: NCBI NCBI Bookshelf.
Online access: National Academy of Sciences National Academies Press.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 i 4500
001 EBOOKCENTRAL_on1002295899
003 OCoLC
005 20240329122006.0
006 m o d
007 cr cn|||||||||
008 170704s2017 dcua obt 000 0 eng
010 |a  2017302113 
040 |a NLM  |b eng  |e rda  |e pn  |c NLM  |d SCB  |d EBLCP  |d YDX  |d MMU  |d MERUC  |d OCLCF  |d MERER  |d N$T  |d OCLCO  |d OCLCA  |d VT2  |d IDB  |d EZ9  |d OCLCQ  |d OCLCO  |d OCLCA  |d G3B  |d IGB  |d STF  |d OCLCQ  |d SFB  |d OCLCQ  |d UKAHL  |d OCLCQ  |d LVT  |d OCLCO  |d K6U  |d OCLCO  |d OCLCQ  |d OCL  |d OCLCO  |d OCLCL 
016 7 |a 101708960  |2 DNLM 
019 |a 992148188  |a 992318214  |a 992570855  |a 1125597526  |a 1125736831  |a 1136366398  |a 1229332464  |a 1262682821 
020 |a 9780309455091  |q (electronic bk.) 
020 |a 030945509X  |q (electronic bk.) 
020 |z 9780309455084 
020 |z 0309455081 
020 |z 030945509X 
024 7 |a 10.17226/24671  |2 doi 
029 0 |a NLM  |b 101708960 
029 1 |a AU@  |b 000068936567 
029 1 |a AU@  |b 000069467724 
029 1 |a AU@  |b 000060679633 
035 |a (OCoLC)1002295899  |z (OCoLC)992148188  |z (OCoLC)992318214  |z (OCoLC)992570855  |z (OCoLC)1125597526  |z (OCoLC)1125736831  |z (OCoLC)1136366398  |z (OCoLC)1229332464  |z (OCoLC)1262682821 
042 |a pcc 
043 |a n-us--- 
050 4 |a QH499 
060 0 0 |a WO 660 
072 7 |a MED  |x 071000  |2 bisacsh 
082 0 4 |a 615 
049 |a UAMI 
100 1 |a Markowitz-Shulman, Ariel,  |e rapporteur. 
245 1 0 |a Exploring the state of the science in the field of regenerative medicine :  |b challenges of and opportunities for cellular therapies : proceedings of a workshop /  |c Ariel Markowitz-Shulman, Erin Hammers-Forstag, Siobhan Addie, and Sarah H. Beachy, rapporteurs ; Forum on Regenerative Medicine, Board on Health Sciences Policy, Health and Medicine Division, the National Academies of Sciences, Engineering, Medicine. 
264 1 |a Washington, DC :  |b National Academies Press,  |c [2017] 
300 |a 1 online resource (1 PDF file (xxi, 114 pages)) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
504 |a Includes bibliographical references. 
520 3 |a Regenerative medicine holds the potential to create living, functional cells and tissues that can be used to repair or replace those that have suffered potentially irreparable damage due to disease, age, traumatic injury, or genetic and congenital defects. The field of regenerative medicine is broad and includes research and development components of gene and cell therapies, tissue engineering, and non-biologic constructs. Although regenerative medicine has the potential to improve health and deliver economic benefits, this relatively new field faces challenges to developing policies and procedures to support the development of novel therapies are both safe and effective. In October 2016, the National Academies of Sciences, Engineering, and Medicine hosted a public workshop with the goal of developing a broad understanding of the opportunities and challenges associated with regenerative medicine cellular therapies and related technologies. Participants explored the state of the science of cell-based regenerative therapies within the larger context of patient care and policy. This publication summarizes the presentations and discussions from the workshop. 
536 |a This project was supported by contracts between the National Academy of Sciences and Akron Biotech (unnumbered contract); Alliance for Regenerative Medicine (unnumbered contract); ALS Association (unnumbered contract); American Association of Gene and Cell Therapy (unnumbered contract); Burroughs Wellcome Fund (Grant #1015949); California Institute for Regenerative Medicine (unnumbered contract); Centre for Commercialization of Regenerative Medicine (unnumbered contract); Christopher & Dana Reeve Foundation (unnumbered contract); Department of Veterans Affairs (Contract No. VA268-16-C-0051); Food and Drug Administration (Grant #1R13FD005355-01); Foundation Fighting Blindness (unnumbered contract); GE Healthcare (unnumbered contract); GlaxoSmithKline (Grant ID: 015948); International Society for Stem Cell Research (unnumbered contract); Johnson & Johnson (unnumbered contract); Juno Therapeutics (unnumbered contract); The Michael J. Fox Foundation for Parkinson's Research (unnumbered contract); National Institute of Standards and Technology (unnumbered contract); National Institutes of Health (Contract No. HHSN263201200074I, Order No. HHSN23600075: National Heart, Lung, and Blood Institute; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Biomedical Imaging and Bioengineering; National Institute of Dental and Craniofacial Research; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Neurological Disorders and Stroke); The New York Stem Cell Foundation (unnumbered contract); Parkinson's Disease Foundation (unnumbered contract); Takeda Development Centers America (Contract #65317); and United Therapeutics Corporation (unnumbered contract). Any opinions, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project. 
588 0 |a Online resource; title from PDF title page (viewed July 17, 2017). 
505 0 |a Introduction -- Skin and musculoskeletal tissues -- Hematologic and immunologic applications -- Neurological and ophthalmological tissues -- Cardiovascular and lung tissues -- Renal tissue -- Looking toward the future: concluding thoughts -- References -- Appendix A: Workshop agenda -- Appendix B: Speaker biographical sketches -- Appendix C: Statement of task -- Appendix D: Registered attendees. 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
650 0 |a Regenerative medicine  |v Congresses. 
650 0 |a Medical policy. 
650 0 |a Medical care. 
650 1 2 |a Cell- and Tissue-Based Therapy  |x methods 
650 1 2 |a Regenerative Medicine  |x methods 
650 2 2 |a Health Policy 
650 2 2 |a Patient Care 
651 2 |a United States 
650 6 |a Médecine régénératrice  |v Congrès. 
650 6 |a Politique sanitaire. 
650 6 |a Soins médicaux. 
650 7 |a MEDICAL  |x Pharmacology.  |2 bisacsh 
650 7 |a Medical policy  |2 fast 
650 7 |a Medical care  |2 fast 
650 7 |a Regenerative medicine  |2 fast 
655 2 |a Congress 
655 7 |a proceedings (reports)  |2 aat 
655 7 |a Conference papers and proceedings  |2 fast 
655 7 |a Conference papers and proceedings.  |2 lcgft 
655 7 |a Actes de congrès.  |2 rvmgf 
700 1 |a Forstag, Erin Hammers,  |e rapporteur. 
700 1 |a Addie, Siobhan,  |e rapporteur. 
700 1 |a Beachy, Sarah H.,  |e rapporteur. 
710 2 |a National Academies of Sciences, Engineering, and Medicine (U.S.).  |b Forum on Regenerative Medicine,  |e issuing body. 
711 2 |a State of the Science in the Field of Regenerative Medicine: Challenges of and Opportunities for Cellular Therapies (Workshop)  |d (2016 :  |c Washington, D.C.) 
758 |i has work:  |a Exploring the state of the science in the field of regenerative medicine (Text)  |1 https://id.oclc.org/worldcat/entity/E39PCFYDtDjfmftgh3bdVpGcxC  |4 https://id.oclc.org/worldcat/ontology/hasWork 
776 0 8 |i Print version:  |a Markowitz-Shulman, Ariel.  |t Exploring the state of the science in the field of regenerative medicine.  |d Washington, DC : National Academies Press, [2017]  |z 9780309455084  |w (OCoLC)992998949 
830 0 |a Online access: NCBI NCBI Bookshelf. 
830 0 |a Online access: National Academy of Sciences National Academies Press. 
856 4 0 |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=4886654  |z Texto completo 
938 |a Askews and Holts Library Services  |b ASKH  |n AH36565796 
938 |a Askews and Holts Library Services  |b ASKH  |n AH36618371 
938 |a EBL - Ebook Library  |b EBLB  |n EBL4886654 
938 |a EBSCOhost  |b EBSC  |n 1546468 
938 |a YBP Library Services  |b YANK  |n 14658564 
994 |a 92  |b IZTAP